Clinical Trial Update: Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether lovastatin can reduce radiation-related side effects in women with breast cancer was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Breast Cancer, Radiation Toxicity | Phase 2 | Status: TERMINATED | Results posted: 2013-05-30